Targeting of an antitumor agent, RS-1541 (palmitoyl-rhizoxin), via low-density lipoprotein receptor

This publication has 16 references indexed in Scilit:

• Contribution of serum lipoproteins as carriers of antitumour agent RS-1541 (palmitoyl rhizoxin) in mice
  Biopharmaceutics & Drug Disposition, 1994
• Comparative study of the incorporation of ellipticine-esters into low density lipoprotein (LDL) and selective cell uptake of drug-LDL complex via the LDL receptor pathway in vitro
  Biochemical Pharmacology, 1990
• Assimilation of LDL by experimental tumours in mice
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
• Rhizoxin binding to tubulin at the maytansine-binding site
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1987
• Studies on macrocyclic lactone antibiotics. XI. Anti-mitotic and anti-tubulin activity of new antitumor antibiotics, rhizoxin and its homologues.
  The Journal of Antibiotics, 1987
• Uptake of 2,3,7,8-tetrachlorodibenzo-p-dioxin from plasma lipoproteins by cultured human fibroblasts
  Chemico-Biological Interactions, 1986
• In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice
  Cancer Letters, 1984
• The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
  Annual Review of Biochemistry, 1977
• The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observations
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972
• THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM
  Journal of Clinical Investigation, 1955